<DOC>
	<DOC>NCT02373540</DOC>
	<brief_summary>The purpose of this study is to obtain real-world clinical outcome data for the Algovita Spinal Cord Stimulation system when used, on-label, according to the applicable directions for use.</brief_summary>
	<brief_title>Algovita Post-Market Clinical Study: Spinal Cord Stimulation to Treat Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Patient is eligible for SCS therapy according to the Algovita SCS system Indications for Use statement Patient had successful Algovita SCS system stimulation trial and will be implanted with a permanent Algovita SCS system Patient is willing and able to sign an IRB/EC approved informed consent Patient is contraindicated for an Algovita SCS system Patient has a cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or complete study assessments Patient has a life expectancy of less than 2 years Patient is participating in another clinical study that would confound data analysis Patient has a coexisting pain condition that might confound pain ratings</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>spinal cord stimulation</keyword>
	<keyword>chronic pain</keyword>
	<keyword>failed back surgery syndrome</keyword>
</DOC>